Your browser doesn't support javascript.
loading
A comparison of social prescribing approaches across twelve high-income countries.
Scarpetti, Giada; Shadowen, Hannah; Williams, Gemma A; Winkelmann, Juliane; Kroneman, Madelon; Groenewegen, Peter P; De Jong, Judith D; Fronteira, Inês; Augusto, Gonçalo Figueiredo; Hsiung, Sonia; Slade, Siân; Rojatz, Daniela; Kallayova, Daniela; Katreniakova, Zuzana; Nagyova, Iveta; Kylänen, Marika; Vracko, Pia; Jesurasa, Amrita; Wallace, Zoe; Wallace, Carolyn; Costongs, Caroline; Barnes, Andrew J; van Ginneken, Ewout.
Afiliación
  • Scarpetti G; Technische Universität Berlin, European Observatory on Health Systems and Policies. Electronic address: giada.scarpetti@tu-berlin.de.
  • Shadowen H; Virginia Commonwealth University, Richmond, Virginia, USA.
  • Williams GA; European Observatory on Health Systems and Policies, World Health Organization.
  • Winkelmann J; European Observatory on Health Systems and Policies, World Health Organization.
  • Kroneman M; Nivel (Netherlands Institute for Health Services Research, Utrecht, the Netherlands.
  • Groenewegen PP; Nivel (Netherlands Institute for Health Services Research, Utrecht, the Netherlands.
  • De Jong JD; Nivel (Netherlands Institute for Health Services Research, Utrecht, Netherlands and Maastricht University.
  • Fronteira I; Global Health and Tropical, Instituto de Higiene e Medicina Tropical, Universidade Nova de Lisboa, Lisboa, Portugal.
  • Augusto GF; Comprehensive Health Research Center (CHRC), Escola Nacional de Saúde Pública (ENSP), Universidade NOVA de Lisboa (UNL), Lisboa, Portugal.
  • Hsiung S; Canadian Institute for Social Prescribing, Canadian Red Cross.
  • Slade S; Nossal Institute for Global Health, University of Melbourne, Australia.
  • Rojatz D; Austrian National Public Health Institute, Vienna, Austria.
  • Kallayova D; Ministry of Health of the Slovak Republic, Bratislava, Slovak Republic.
  • Katreniakova Z; Department of Social and Behavioural Medicine, Faculty of Medicine, PJ Safarik University in Kosice and Slovak Public Health Association (SAVEZ), Kosice, Slovak Republic.
  • Nagyova I; Department of Social and Behavioural Medicine, Faculty of Medicine, PJ Safarik University in Kosice and Slovak Public Health Association (SAVEZ), Kosice, Slovak Republic.
  • Kylänen M; Finnish Best Practice Portal for Health and Wellbeing Promotion, Finnish Institute for Health and Welfare (THL), Helsinki, Finland.
  • Vracko P; National Institute of Public Health, Ljubljana, Slovenia.
  • Jesurasa A; Public Health Wales, Cardiff.
  • Wallace Z; Public Health Wales, Cardiff.
  • Wallace C; University of South Wales, Wales School for Social Prescribing Research (WSSPR), UK.
  • Costongs C; EuroHealth Net, Belgium.
  • Barnes AJ; Virginia Commonwealth University, Richmond, Virginia, USA.
  • van Ginneken E; Technische Universität Berlin, European Observatory on Health Systems and Policies.
Health Policy ; 142: 104992, 2024 Apr.
Article en En | MEDLINE | ID: mdl-38368661
ABSTRACT

BACKGROUND:

Social prescribing connects patients with community resources to improve their health and well-being. It is gaining momentum globally due to its potential for addressing non-medical causes of illness while building on existing resources and enhancing overall health at a relatively low cost. The COVID-19 pandemic further underscored the need for policy interventions to address health-related social issues such as loneliness and isolation.

AIM:

This paper presents evidence of the conceptualisation and implementation of social prescribing schemes in twelve countries Australia, Austria, Canada, England, Finland, Germany, Portugal, the Slovak Republic, Slovenia, the Netherlands, the United States and Wales.

METHODS:

Twelve countries were identified through the Health Systems and Policy Monitor (HSPM) network and the EuroHealthNet Partnership. Information was collected through a twelve open-ended question survey based on a conceptual model inspired by the WHO's Health System Framework.

RESULTS:

We found that social prescribing can take different forms, and the scale of implementation also varies significantly. Robust evidence on impact is scarce and highly context-specific, with some indications of cost-effectiveness and positive impact on well-being.

CONCLUSIONS:

This paper provides insights into social prescribing in various contexts and may guide countries interested in holistically tackling health-related social factors and strengthening community-based care. Policies can support a more seamless integration of social prescribing into existing care, improve collaboration among sectors and training programs for health and social care professionals.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Pandemias / COVID-19 Límite: Humans País/Región como asunto: America do norte / Europa Idioma: En Revista: Health Policy Asunto de la revista: PESQUISA EM SERVICOS DE SAUDE / SAUDE PUBLICA Año: 2024 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Pandemias / COVID-19 Límite: Humans País/Región como asunto: America do norte / Europa Idioma: En Revista: Health Policy Asunto de la revista: PESQUISA EM SERVICOS DE SAUDE / SAUDE PUBLICA Año: 2024 Tipo del documento: Article